Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Jones

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Seminars in Respiratory and Critical Care Medicine|May 28, 2016
Recent Advances and Future Needs in Interstitial Lung DiseasesMark G Jones, Luca Richeldi
Respiration; International Review of Thoracic Diseases|December 4, 2013
Idiopathic pulmonary fibrosis: recent trials and current drug therapyMark G Jones, Sophie Fletcher, Luca Richeldi
Lancet (London, England)|April 3, 2017
Idiopathic pulmonary fibrosisLuca Richeldi, Harold R Collard, Mark G Jones
Current Opinion in Pulmonary Medicine|July 24, 2020
Immunology of sarcoidosis: old companions, new relationshipsFrancesco Cinetto, Riccardo Scarpa, Alessandro Dell'Edera, et al.
Thorax|February 22, 2023
Topological data analysis identifies molecular phenotypes of idiopathic pulmonary fibrosisAndrew Shapanis, Mark G Jones, James Schofield, et al.
Journal of Lung Health and Diseases|April 30, 2019
Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talkCharlotte Hill, Mark G Jones, Donna E Davies, et al.
Cureus|September 13, 2021
Fatality Rate and Survival Time of Laboratory-Confirmed COVID-19 for Patients in England During the First Wave of SARS-CoV-2 Infection: A Modelling StudyChristopher R Hillyar, Anjan Nibber, Christine E Jones, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 22, 2005
Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndromeMark G Jones, C Stewart Goodwin, Saira Amjad, et al.
Current Opinion in Pulmonary Medicine|February 16, 2017
Personalized medicine in interstitial lung diseasesPaolo Spagnolo, Justin M Oldham, Mark G Jones, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 13, 2005
CFSUM1 and CFSUM2 in urine from patients with chronic fatigue syndrome are methodological artefactsRonald A Chalmers, Mark G Jones, C Stewart Goodwin, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Seminars in Respiratory and Critical Care Medicine|May 28, 2016
Recent Advances and Future Needs in Interstitial Lung DiseasesMark G Jones, Luca Richeldi
Respiration; International Review of Thoracic Diseases|December 4, 2013
Idiopathic pulmonary fibrosis: recent trials and current drug therapyMark G Jones, Sophie Fletcher, Luca Richeldi
Lancet (London, England)|April 3, 2017
Idiopathic pulmonary fibrosisLuca Richeldi, Harold R Collard, Mark G Jones
Current Opinion in Pulmonary Medicine|July 24, 2020
Immunology of sarcoidosis: old companions, new relationshipsFrancesco Cinetto, Riccardo Scarpa, Alessandro Dell'Edera, et al.
Thorax|February 22, 2023
Topological data analysis identifies molecular phenotypes of idiopathic pulmonary fibrosisAndrew Shapanis, Mark G Jones, James Schofield, et al.
Journal of Lung Health and Diseases|April 30, 2019
Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talkCharlotte Hill, Mark G Jones, Donna E Davies, et al.
Cureus|September 13, 2021
Fatality Rate and Survival Time of Laboratory-Confirmed COVID-19 for Patients in England During the First Wave of SARS-CoV-2 Infection: A Modelling StudyChristopher R Hillyar, Anjan Nibber, Christine E Jones, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 22, 2005
Plasma and urinary carnitine and acylcarnitines in chronic fatigue syndromeMark G Jones, C Stewart Goodwin, Saira Amjad, et al.
Current Opinion in Pulmonary Medicine|February 16, 2017
Personalized medicine in interstitial lung diseasesPaolo Spagnolo, Justin M Oldham, Mark G Jones, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 13, 2005
CFSUM1 and CFSUM2 in urine from patients with chronic fatigue syndrome are methodological artefactsRonald A Chalmers, Mark G Jones, C Stewart Goodwin, et al.
Pageof 6